Published in J Infect Dis on April 01, 1982
Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev (1988) 4.76
Effects of global climate on infectious disease: the cholera model. Clin Microbiol Rev (2002) 4.38
Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A (1983) 2.90
Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci U S A (2006) 2.03
Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme. Infect Immun (1983) 1.74
Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect Immun (1983) 1.67
Production and partial characterization of an elastolytic protease of Vibrio vulnificus. Infect Immun (1985) 1.42
Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun (2000) 1.21
Rapid growth of planktonic Vibrio cholerae non-O1/non-O139 strains in a large alkaline lake in Austria: dependence on temperature and dissolved organic carbon quality. Appl Environ Microbiol (2008) 1.15
Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr (2008) 1.14
TagA is a secreted protease of Vibrio cholerae that specifically cleaves mucin glycoproteins. Microbiology (2010) 0.97
Intestinal microbial flora after feeding phytohemagglutinin lectins (Phaseolus vulgaris) to rats. Appl Environ Microbiol (1985) 0.81
Pathogenic E. coli exploits SslE mucinase activity to translocate through the mucosal barrier and get access to host cells. PLoS One (2015) 0.79
BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem (2000) 2.74
Identification and preliminary characterization of Vibrio cholerae outer membrane proteins. J Bacteriol (1981) 2.58
In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae. Infect Immun (1979) 2.50
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun (1984) 2.42
Isolation and characterization of protease-deficient mutants of vibrio cholerae. J Infect Dis (1978) 2.19
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir. Antimicrob Agents Chemother (2001) 2.00
Survival and multiplication of Vibrio cholerae in the upper bowel of infant mice. Infect Immun (1978) 1.95
Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect Immun (1982) 1.92
Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells. Infect Immun (1978) 1.89
Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun (1987) 1.69
Isolation and characterization of the fertility factor P of Vibrio cholerae. J Bacteriol (1973) 1.56
Isolation and phenotypic characterization of virulence-deficient mutants of Vibrio cholerae. Infect Immun (1978) 1.53
Interaction of monoclonal antibodies with pertussis toxin and its subunits. Infect Immun (1984) 1.40
In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae. Infect Immun (1980) 1.28
Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol (1986) 1.25
Pertussis outbreak in Austin and Travis County, Texas, 1975. J Clin Microbiol (1977) 1.17
Isolation and characterization of monoclonal antibodies to Bordetella pertussis. J Biol Stand (1984) 1.15
Identification and characterization of Vibrio cholerae surface proteins by radioiodination. Infect Immun (1985) 1.15
Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol (1985) 1.11
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
Antibiotic susceptibility testing of Bordetella pertussis. Am J Clin Pathol (1980) 1.09
Aspergillosis in gamebirds and ducks. Vet Rec (2011) 1.07
Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel. Infect Immun (1981) 1.02
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane. Infect Immun (1985) 0.99
Plasmid-mediated changes in virulence of Vibrio cholerae. Infect Immun (1986) 0.99
Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent. Int Immunopharmacol (2001) 0.96
Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. Infect Immun (1990) 0.95
Effects of fatty acids on growth of Bordetella pertussis in defined medium. J Clin Microbiol (1979) 0.95
Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93
A model for enzymatic isomerization of D-glucose to D-fructose in a batch reactor. Biotechnol Bioeng (1976) 0.92
Characterization of Vibrio cholerae protease activities with peptide digest analysis. J Clin Microbiol (1981) 0.90
Variability in derivative strains of Bordetella pertussis. Dev Biol Stand (1980) 0.90
Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMP. Life Sci (1984) 0.90
Characterization of intestinal brush border guanylate cyclase activation by Escherichia coli heat-stable enterotoxin. Arch Biochem Biophys (1986) 0.89
Comparison of the effects of depolarizing agents and neurotransmitters on regional CNS cyclic GMP levels in various animals. J Neurochem (1976) 0.88
Function of solids in anaerobic lagoon treatment of wastewater. J Water Pollut Control Fed (1968) 0.87
Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood (1981) 0.86
Isolation and characterization of the Vibrio cholerae recA gene. J Bacteriol (1986) 0.84
Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J Biol Chem (1998) 0.84
Analysis of the structural requirements for lysosomal membrane targeting using transferrin receptor chimeras. J Biol Chem (1998) 0.83
Surface antigens of Bordetella pertussis. Adv Exp Med Biol (1985) 0.81
Cell surface antigens of Bordetella pertussis. Dev Biol Stand (1985) 0.81
Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents. Infect Immun (1986) 0.79
Microwave radiation energy: a probe for the neurobiologist. Life Sci (1981) 0.79
Regulation of intestinal mucosa guanylate cyclase by hemin, heme and protoporphyrin IX. Biochim Biophys Acta (1987) 0.79
Future fitness of female insect pests in temporally stable and unstable habitats and its impact on habitat utility as refugees for insect resistance management. J Insect Sci (2009) 0.78
Solubilization and reprecipitation from intestinal brush border membranes of a complex containing guanylate cyclase activatable by the heat-stable enterotoxin. Arch Biochem Biophys (1991) 0.78
Gastrin antibodies: induction, demonstration, and specificity. Science (1967) 0.78
Immunoblastic sarcoma of T- and B-cell types: morphologic description and comparison. Hum Pathol (1985) 0.78
Age-dependent changes in affinity-labeled receptors for Escherichia coli heat-stable enterotoxin in the swine intestine. Infect Immun (1991) 0.77
Characterization of an oxidative stress response regulator, homologous to Escherichia coli OxyR, from the phytopathogen Xylella fastidiosa. Protein Expr Purif (2010) 0.77
Development and use of a nonrestraining waveguide chamber for rapid microwave radiation killing of the mouse and neonate rat. J Pharmacol Methods (1982) 0.76
Activation of intestinal brush border guanylate cyclase by aromatic disulphide compounds. Biochem J (1991) 0.76
Nucleotide regulation of heat-stable enterotoxin receptor binding and of guanylate cyclase activation. Biochem J (1992) 0.75
Multiband appliances. Dent Pract Dent Rec (1966) 0.75
Performance characteristics of a multimedia system for clinical data management. Cancer Pract (1994) 0.75
Cerebral blood flow after treatment with ORG-2766, a potent analog of ACTH 4--9. Pharmacol Biochem Behav (1979) 0.75
An automated microprocessor-controlled data collection device for use with the Technicon AutoAnalyzer system. J Pharmacol Methods (1982) 0.75
Subcellular fractions for immunizing against pertussis. Dev Biol Stand (1978) 0.75
[Bilateral cleft lip and palate, surgical repositioning of the premaxilla: comparative study]. Mondo Ortod (1988) 0.75
The radiographic assessment and subsequent management of unerupted teeth. Br J Orthod (1974) 0.75
Variations in the treatment of bilateral clefts of lip and palate. Rep Congr Eur Orthod Soc (1967) 0.75
A pilot study to assess the validity of the Orthodontic Treatment Priority Index in English schoolchildren. Community Dent Oral Epidemiol (1974) 0.75
Orthodontics in the general dental services (a review of its aims, methods and achievements). Br J Orthod (1986) 0.75
Modelling of control options for an outbreak of Mycoplasma gallisepticum in egg production: a decision support tool. Vet J (2013) 0.75
Increased monoamine oxidase activity produced by general inhalation anesthetic agents. Arch Int Pharmacodyn Ther (1974) 0.75
Alpha 1-antitrypsin and lysozyme in fibrous papules and angiofibromas. J Am Acad Dermatol (1985) 0.75
Mixing of 10-microm radiation in room-temperature Schottky diodes. Opt Lett (1981) 0.75
The provision of orthodontic care in the National Health Service in England and Wales. Trans Eur Orthod Soc (1974) 0.75
Bar coding technology and its applications in emergency care. J Emerg Nurs (1996) 0.75
On the use of microwave radiation energy for brain tissue fixation. J Neurochem (1982) 0.75
Cryogenic solvents inhibit the binding of the Escherichia coli heat-stable enterotoxin to intestinal brush border membranes. Arch Biochem Biophys (1993) 0.75
Cyclic nucleotides in the rat neostriatum: push-pull perfusion studies. Brain Res (1979) 0.75
Effect of diesel particulate exposure on adenylate and guanylate cyclase of rat and guinea pig liver and lung. J Appl Toxicol (1981) 0.75
'The great debate'. Br Dent J (1989) 0.75
Effect of jejunal loop location on the activity of Escherichia coli heat-stable enterotoxin in 4- to 5-week-old pigs. Am J Vet Res (1987) 0.75
Desglycyl-8-arginine vasopressin affects regional mouse brain cyclic AMP content. Pharmacol Biochem Behav (1982) 0.75
Contract negotiation. The basics. Comput Nurs (1997) 0.75
[Initial reports on experiences in working with special groups in child day care centers]. Psychiatr Neurol Med Psychol Beih (1979) 0.75
Cyclic AMP in female mouse brain is altered by the adrenocorticotropic hormone(4-9) analogue organon 2766. J Neurochem (1981) 0.75
Hospital and community orthodontic services in Leicestershire. A report on co-operation between services. Br Dent J (1975) 0.75